Investors & Media

At Bachem, we believe in open and transparent dialogue with both the financial community and public media.

As a company listed on the Swiss stock exchange, we provide regular information on the strategy and current situation of our company as well as on planned and expected future developments.

On these pages, we have compiled the most important information for shareholders and representatives of the capital markets as well as for media representatives, and we update it regularly.

Your contact at Bachem for investor and media enquiries:

Dr. Daniel Grotzky

Head Group Communications

Bachem Holding AG
Hauptstrasse 144
4416 Bubendorf

Tel +41 58 595 2021 (Direct: -3806)

Investor enquiries:

Media enquiries:

Please state your outlet (financial institution or media outlet) and any relevant deadline for information when reaching out to us.


to our press releases and investor news

Click here >>

Financial reports

View all annual reports or order hard copies
Learn more

Latest financial news

  • All
  • Ad-hoc
  • Finance

Financial events

Find out about our next upcoming financial events.
Learn more

Corporate governance

Board of Directors

Bachem’s Board of Directors are responsible for defining the corporate strategy and are elected by the company shareholders.

Corporate Executive Committee

Responsible for managing Bachem worldwide and for implementing policies and strategies as defined by the Board of Directors.

Code of Conduct

The basis for the behavior which we demonstrate day by day. This Code of Conduct forms an integral part for everyone at Bachem.

Statuten /
Articles of Association of Bachem Holding AG

Analyst coverage

As a stock listed company, Bachem is as a company reviewed and commented upon by analysts on a regular basis. According to our best knowledge, the hereunder mentioned finance institutions prepare and issue Bachem related reports. There is no guarantee regarding the completeness and correctness of the list, although we strive to maintain and update it. Bachem does not comment on any analyst report and disclaims any liability in relation with statements or recommendations made therein as well as transactions based thereon.


Baader Helvea AG

Leonildo Delgado, PhD,
Director Equity Research 

+41 43 388 9226


Vineet Agrawal,

+44 020 7984 8274

Mirabaud Securities Limited

Dr. Anja Pomrehn,
Senior Medical Technology and Chemical Equity Analyst

+41 44 798 24 68

Octavian AG

LAURA pfeifer-rossi

+41 44 520 06 29

Research Partners AG

Dr. Martin Vögtli

+41 44 533 40 30


Barbora Blaha

+41 44 238 95 61


Sibylle Bischofberger,
Senior Analyst Equity Research

+41 58 283 70 21

Royal Bank of Canada Europe Ltd

Charles Weston, CFA,
Director, European Healthcare Equity Research

 +44 20 7429 8425

Contact us

"*" indicates required fields

Fields marked with an asterisk (*) are required

Submission Time
This field is for validation purposes and should be left unchanged.